Sign in | Sign up

Thank you for taking steps to ID PPID!

Our study is designed to help identify new cases of equine pituitary pars intermedia
dysfunction (PPID), the most commonly diagnosed equine endocrinopathy.1

Criteria for Testing:

In order for a horse to be considered for testing, we request the following:

  • The horse has not been previously diagnosed with PPID (only newly diagnosed cases).
  • Horses previously diagnosed with PPID can still be tested if they are currently being treated with compounded pergolide.
  • The horse should be exhibiting one or more of these signs:
    1. Hirsutism/Hypertrichosis (decreased shedding)
    2. Laminitis
    3. Abnormal fat distribution such as
      1. Cresty neck
      2. Bulging supraorbital fat
      3. Fat pads at tailhead or inguinal area
    4. Lethargy
    5. Polyuria
    6. Polydipsia
    7. Susceptibility to infections
    8. Abnormal sweating
    9. Inappropriate lactation

Get Started:

  • Identify up to three horses in your practice that you would like to request tests for based on the above criteria.
    1. Complete an enrollment form for each horse (next page)
    2. Complete the Cornell submission form (sent in enrollment follow up e-mail)
    3. Prepare your sample shipments. For each horse, include:
      1. Completed Cornell submission form
      2. Tube containing serum
      3. Tube containing plasma
      4. Cold pack

NOTE: Enrollment and submission forms from past years will not be accepted during this promotion period.

Resting insulin
For the assessment of resting insulin do not feed grain within 4 hours of testing. See feeding instructions in reference section prior to pulling blood sample for resting insulin. Please follow normal management practices (leave on hay and/or pasture) except no grain should be consumed within 4 hours of pulling blood sample submitted for insulin levels.

Boehringer Ingelheim Vetmedica, Inc. reserves the right to end or modify the program, in whole or in part, at any time without notice. The program is available to only practicing veterinarians with valid veterinary-client patient relationships.

Enrollment Form

Important safety information

PRASCEND is for use in horses only. Treatment with PRASCEND may cause loss of appetite. Most cases are mild. Weight loss, lack of energy and behavioral changes also may be observed. If severe, a temporary dose reduction may be necessary. PRASCEND has not been evaluated in breeding, pregnant or lactating horses and may interfere with reproductive hormones in these horses. Using PRASCEND at the same time as drugs known as dopamine antagonists should be avoided. These drugs may diminish the effectiveness of PRASCEND. If your horse is especially sensitive to pergolide mesylate or similar products, PRASCEND should not be used. Refer to the package insert for complete product information.

Reference

1Donaldson MT, McDonnell SM, Schanbacher BJ, et al. Variation in plasma adrenocorticotriopic hormone concentration and
dexamethasone suppression test results with season, age and sex in healthy ponies and horses. J Vet Intern Med
2005;19(2):217–222.